WPD Pharmaceuticals Inc.
WBIO
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 34.80K | -13.90K | -116.90K | 90.00K | -64.00K |
| Total Depreciation and Amortization | 2.00K | 2.00K | 2.00K | 2.10K | 2.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -74.90K | -46.30K | 11.40K | -131.40K | 13.30K |
| Change in Net Operating Assets | 15.00K | 52.50K | 47.90K | -3.00K | 14.10K |
| Cash from Operations | -23.20K | -5.70K | -55.60K | -42.30K | -34.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 5.40K | -- | -- | -- | -- |
| Cash from Investing | 5.40K | -- | -- | -- | -- |
| Total Debt Issued | 30.50K | -- | -- | -32.80K | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 32.80K | -32.80K |
| Cash from Financing | 22.40K | -- | -- | 0.00 | -24.50K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.60K | -5.70K | -55.60K | -42.30K | -58.50K |
